These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37419001)

  • 1. Innovative approaches for the control of ticks and tick-borne diseases.
    de la Fuente J; Mazuecos L; Contreras M
    Ticks Tick Borne Dis; 2023 Nov; 14(6):102227. PubMed ID: 37419001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological control of ticks and tick-borne diseases that impact cattle health and production.
    Almazan C; Tipacamu GA; Rodriguez S; Mosqueda J; Perez de Leon A
    Front Biosci (Landmark Ed); 2018 Mar; 23(8):1535-1551. PubMed ID: 29293449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with proteins involved in tick-pathogen interactions reduces vector infestations and pathogen infection.
    Merino O; Antunes S; Mosqueda J; Moreno-Cid JA; Pérez de la Lastra JM; Rosario-Cruz R; Rodríguez S; Domingos A; de la Fuente J
    Vaccine; 2013 Dec; 31(49):5889-96. PubMed ID: 24084474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tick vaccines and the transmission of tick-borne pathogens.
    de la Fuente J; Kocan KM; Blouin EF
    Vet Res Commun; 2007 Aug; 31 Suppl 1():85-90. PubMed ID: 17682852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinomics, the new road to tick vaccines.
    de la Fuente J; Merino O
    Vaccine; 2013 Dec; 31(50):5923-9. PubMed ID: 24396872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological control of ticks through vaccination with Boophilus microplus gut antigens.
    De La Fuente J; Rodríguez M; García-García JC
    Ann N Y Acad Sci; 2000; 916():617-21. PubMed ID: 11193686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of cattle with TickGARD induces cross-reactive antibodies binding to conserved linear peptides of Bm86 homologues in Boophilus decoloratus.
    Odongo D; Kamau L; Skilton R; Mwaura S; Nitsch C; Musoke A; Taracha E; Daubenberger C; Bishop R
    Vaccine; 2007 Jan; 25(7):1287-96. PubMed ID: 17070625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the identification and characterization of protective antigens for recombinant vaccines against tick infestations.
    de la Fuente J; Kocan KM
    Expert Rev Vaccines; 2003 Aug; 2(4):583-93. PubMed ID: 14711342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for new and improved vaccines against ticks and tick-borne diseases.
    de la Fuente J; Kopáček P; Lew-Tabor A; Maritz-Olivier C
    Parasite Immunol; 2016 Dec; 38(12):754-769. PubMed ID: 27203187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of ticks resistant to immunization with Bm86 in cattle vaccinated with the recombinant antigen Bm95 isolated from the cattle tick, Boophilus microplus.
    García-García JC; Montero C; Redondo M; Vargas M; Canales M; Boue O; Rodríguez M; Joglar M; Machado H; González IL; Valdés M; Méndez L; de la Fuente J
    Vaccine; 2000 Apr; 18(21):2275-87. PubMed ID: 10717348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation among Bm86 sequences in Rhipicephalus (Boophilus) microplus ticks collected from cattle across Thailand.
    Kaewmongkol S; Kaewmongkol G; Inthong N; Lakkitjaroen N; Sirinarumitr T; Berry CM; Jonsson NN; Stich RW; Jittapalapong S
    Exp Appl Acarol; 2015 Jun; 66(2):247-56. PubMed ID: 25777941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of tick infestations and pathogen prevalence in cattle and sheep farms vaccinated with the recombinant Subolesin-Major Surface Protein 1a chimeric antigen.
    Torina A; Moreno-Cid JA; Blanda V; Fernández de Mera IG; de la Lastra JM; Scimeca S; Blanda M; Scariano ME; Briganò S; Disclafani R; Piazza A; Vicente J; Gortázar C; Caracappa S; Lelli RC; de la Fuente J
    Parasit Vectors; 2014 Jan; 7():10. PubMed ID: 24398155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches towards tick and tick-borne diseases control.
    Domingos A; Antunes S; Borges L; Rosário VE
    Rev Soc Bras Med Trop; 2013; 46(3):265-9. PubMed ID: 23559344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ferritin 2 for the control of tick infestations.
    Hajdusek O; Almazán C; Loosova G; Villar M; Canales M; Grubhoffer L; Kopacek P; de la Fuente J
    Vaccine; 2010 Apr; 28(17):2993-8. PubMed ID: 20171306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Rhipicephalus (Boophilus) microplus Bm86 against Hyalomma dromedarii and Amblyomma cajennense tick infestations in camels and cattle.
    Rodríguez-Valle M; Taoufik A; Valdés M; Montero C; Ibrahin H; Hassan SM; Jongejan F; de la Fuente J
    Vaccine; 2012 May; 30(23):3453-8. PubMed ID: 22446633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseases.
    Lew-Tabor AE; Rodriguez Valle M
    Ticks Tick Borne Dis; 2016 Jun; 7(4):573-85. PubMed ID: 26723274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling ticks and tick-borne diseases…looking forward.
    de la Fuente J
    Ticks Tick Borne Dis; 2018 Jul; 9(5):1354-1357. PubMed ID: 29656834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational biotechnology for the control of ticks and tick-borne diseases.
    de la Fuente J
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101738. PubMed ID: 34023540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two initial vaccinations with the Bm86-based Gavacplus vaccine against Rhipicephalus (Boophilus) microplus induce similar reproductive suppression to three initial vaccinations under production conditions.
    Vargas M; Montero C; Sánchez D; Pérez D; Valdés M; Alfonso A; Joglar M; Machado H; Rodríguez E; Méndez L; Lleonart R; Suárez M; Fernández E; Estrada MP; Rodríguez-Mallón A; Farnós O
    BMC Vet Res; 2010 Sep; 6():43. PubMed ID: 20846415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tick vaccines: current status and future directions.
    de la Fuente J; Contreras M
    Expert Rev Vaccines; 2015; 14(10):1367-76. PubMed ID: 26289976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.